cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Avita Therapeutics Inc Com
5 own
3 watching
Current Price
$8.87
$-0.51
(-5.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
13.63M
52-Week High
52-Week High
21.70000
52-Week Low
52-Week Low
8.78000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization13.63M
icon52-Week High21.70000
icon52-Week Low8.78000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Avita Therapeutics Inc Com do?
Avita Medical Limited operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.
Read More
How much money does Avita Therapeutics Inc Com make?
News & Events about Avita Therapeutics Inc Com.
Globe Newswire
9 months ago
VALENCIA, Calif., and MELBOURNE, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced ...
GuruFocus
10 months ago
Related Stocks: RCEL...
Globe Newswire
1 year ago
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, invites ...
Globe Newswire
1 year ago
VALENCIA, Calif., and MELBOURNE, Australia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today ...
Globe Newswire
1 year ago
VALENCIA, Calif. and MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ...
Frequently Asked Questions
Frequently Asked Questions
What is Avita Therapeutics Inc Com share price today?
plus_minus_icon
Can Indians buy Avita Therapeutics Inc Com shares?
plus_minus_icon
How can I buy Avita Therapeutics Inc Com shares from India?
plus_minus_icon
Can Fractional shares of Avita Therapeutics Inc Com be purchased?
plus_minus_icon
What are the documents required to start investing in Avita Therapeutics Inc Com stocks?
plus_minus_icon
What is today’s traded volume of Avita Therapeutics Inc Com?
plus_minus_icon
What is today’s market capitalisation of Avita Therapeutics Inc Com?
plus_minus_icon
What is the 52-Week High and Low Range of Avita Therapeutics Inc Com?
plus_minus_icon
What percentage is Avita Therapeutics Inc Com down from its 52-Week High?
plus_minus_icon
What percentage is Avita Therapeutics Inc Com up from its 52-Week Low?
plus_minus_icon
Current Price
$8.87
$-0.51
(-5.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
CLEARPOINT NEURO INC
CLEARPOINT NEURO INC
$5.37
$-0.16 (-2.89 %)
Anixa Biosciences, Inc.
Anixa Biosciences, Inc.
$3.10
$0.05 (1.64 %)
Bioventus Inc
Bioventus Inc
$4.57
$-0.13 (-2.77 %)
Apyx Medical Corp
Apyx Medical Corp
$1.37
$0.05 (3.79 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
CLEARPOINT NEURO INC
CLEARPOINT NEURO INC
$5.37
$-0.16 (-2.89 %)
Anixa Biosciences, Inc.
Anixa Biosciences, Inc.
$3.10
$0.05 (1.64 %)
Bioventus Inc
Bioventus Inc
$4.57
$-0.13 (-2.77 %)
Apyx Medical Corp
Apyx Medical Corp
$1.37
$0.05 (3.79 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00